Myriad Genetics buy Raymond James
Start price
25.02.25
/
50%
€11.40
Target price
25.02.26
€18.10
Performance (%)
-56.14%
Price
07:36
?
Summary
This prediction is currently active. Massive losses of -56.14% have been the result for the BUY prediction by Raymond_James. This prediction currently runs until 25.02.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 6.250% | 6.250% |
| iShares Core DAX® | 1.043% | -0.149% |
| iShares Nasdaq 100 | 1.920% | 4.604% |
| iShares Nikkei 225® | 4.840% | 8.328% |
| iShares S&P 500 | 1.567% | 3.310% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $19.00 price target on the stock, down previously from $27.00.
Ratings data for MYGN provided by MarketBeat